Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Optimizing CRO and Vendor Selection - Examples from the Field Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Opening Keynote: The Future of Rare Disease Trials
Opening Keynotes, • 9/22/25 Opening Keynote: The Evolving Regulatory Environment for Rare Disease Trials Next Opening Keynote: The Future of Rare Disease Trials You Might Also Like Designing Trials with the End in Mind: Building Market Access into Rare Disease Clinical Development Adaptive & Precision-Driven Trials: Platform and MATCH Models for Rare Disease Breakthroughs Optimizing CRO and Vendor Selection - Examples from the Field Closing Panel: Beyond “One Disease At a Time”: Platform Approaches to Accelerate Gene Therapy Trials Opening Keynote: The Future of Rare Disease Trials
